Two victims of diethylstilbestrol win lawsuitBMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7350.1354/d (Published 08 June 2002) Cite this as: BMJ 2002;324:1354
- Alexander Dorozynski
Two women who developed cancer after their mothers took the drug diethylstilbestrol have won their case against the pharmaceutical company UCB Pharma.
The company continued to market the drug until 1977, six years after it was found to be associated with an increase in vaginal cancer in girls and young women whose mothers had taken it, and six years after it was taken off the market in the United States. This is the first successful suit involving the drug in France.
The court ordered the company to pay each of the women €15 244 (£9634; $13 994) as an interim payment, until full damages are …
Log in using your username and password
Log in through your institution
Sign up for a free trial